ACM
XTNT icon

Altium Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Altium Capital Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,252,998
Closed -$3.41M – 19
2025
Q1 		$3.41M Sell
7,252,998
-162,415
-2% -$85.5K 8.21% 4
2024
Q4 		$3.29M Hold
7,415,413
– – 0.93% 35
2024
Q3 		$5.01M Hold
7,415,413
– – 1.48% 26
2024
Q2 		$4.67M Sell
7,415,413
-232,460
-3% -$185K 1.91% 21
2024
Q1 		$8.95M Sell
7,647,873
-379,720
-5% -$416K 3.54% 9
2023
Q4 		$9.07M Sell
8,027,593
-906,769
-10% -$1.07M 6.16% 6
2023
Q3 		$9.83M Buy
8,934,362
+2,706,803
+43% +$2.9M 5.13% 5
2023
Q2 		$5.79M Hold
6,227,559
– – 4.38% 7
2023
Q1 		$3.97M Sell
6,227,559
-18,732
-0.3% -$13.7K 2.2% 16
2022
Q4 		$4.12M Hold
6,246,291
– – 2.1% 15
2022
Q3 		$4.5M Hold
6,246,291
– – 1.65% 13
2022
Q2 		$3.25M Hold
6,246,291
– – 1.3% 27
2022
Q1 		$4.25M Hold
6,246,291
– – 1.42% 27
2021
Q4 		$3.5M Sell
6,246,291
-8,167
-0.1% -$7.7K 0.96% 40
2021
Q3 		$6.94M Sell
6,254,458
-2,038,144
-25% -$2.65M 1.82% 7
2021
Q2 		$13.5M Buy
+8,292,602
New +$14.7M 3.14% 2

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Altium Capital Management's XTNT Position: Q2 2025 in Review

Altium Capital Management sold out of Xtant Medical Holdings (XTNT) in Q2 2025, closing a stake of 7,252,998 shares — an estimated $3.41M sold.

Altium Capital Management first reported a position in XTNT in Q2 2021 and held it in 16 quarters. The position peaked at $13.5M in Q2 2021. 30 funds tracked by Wall St. Rank hold XTNT as of Q2 2025.

  • Altium Capital Management reported no remaining Xtant Medical Holdings position as of Q2 2025 after selling out during the quarter.
  • Altium Capital Management sold 7,252,998 Xtant Medical Holdings shares in Q2 2025, an estimated $3.41M.
  • Altium Capital Management first reported a position in Xtant Medical Holdings in Q2 2021 and held it in 16 quarters.
  • Altium Capital Management's Xtant Medical Holdings position peaked at $13.5M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2025.

Based on Altium Capital Management's 13F filing for Q2 2025.